These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8548943

  • 1. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone.
    Ramos-Dias JC, Yateman M, Camacho-Hübner C, Grossman A, Lengyel AM.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):583-9. PubMed ID: 8548943
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism.
    Lee EJ, Kim KR, Lee HC, Cho JH, Nam MS, Nam SY, Song YD, Lim SK, Huh KB.
    Metabolism; 1995 Nov; 44(11):1509-12. PubMed ID: 7476342
    [Abstract] [Full Text] [Related]

  • 5. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of methimazole treatment on growth hormone (GH) response to GH-releasing hormone in patients with hyperthyroidism.
    Giustina A, Ferrari C, Bodini C, Buffoli MG, Legati F, Schettino M, Zuccato F, Wehrenberg WB.
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):613-8. PubMed ID: 2284886
    [Abstract] [Full Text] [Related]

  • 10. Effect of arginine on the GHRH-stimulated GH secretion in patients with hyperthyroidism.
    Giustina A, Schettino M, Bussi AR, Legati F, Licini M, Zuccato F, Wehrenberg WB.
    Horm Res; 1992 Dec; 38(5-6):256-9. PubMed ID: 1307747
    [Abstract] [Full Text] [Related]

  • 11. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J, Blackman MR, Busby-Whitehead J, Tsiao C, Stewart KJ, Tobin J, Stevens T, Bellantoni MF, Rogers MA, Baumann G, Roth J, Harman SM, Spencer RG.
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [Abstract] [Full Text] [Related]

  • 12. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
    Gianotti L, Arvat E, Valetto MR, Ramunni J, Di Vito L, Maccagno B, Camanni F, Ghigo E.
    Biol Psychiatry; 1998 Feb 01; 43(3):181-7. PubMed ID: 9494699
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR.
    J Clin Endocrinol Metab; 1992 Aug 01; 75(2):530-5. PubMed ID: 1379256
    [Abstract] [Full Text] [Related]

  • 14. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.
    Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJ, Valcavi R.
    J Clin Endocrinol Metab; 1993 Apr 01; 76(4):950-5. PubMed ID: 7682563
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism.
    Pimentel-Filho FR, Ramos-Dias JC, Ninno FB, Façanha CF, Liberman B, Lengyel AM.
    Clin Endocrinol (Oxf); 1997 Mar 01; 46(3):295-300. PubMed ID: 9156038
    [Abstract] [Full Text] [Related]

  • 16. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1997 Feb 01; 82(2):590-9. PubMed ID: 9024260
    [Abstract] [Full Text] [Related]

  • 17. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
    Broglio F, Fubini A, Morello M, Arvat E, Aimaretti G, Gianotti L, Boghen MF, Deghenghi R, Mangiardi L, Ghigo E.
    Clin Endocrinol (Oxf); 1999 Apr 01; 50(4):417-30. PubMed ID: 10468900
    [Abstract] [Full Text] [Related]

  • 18. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M, Invitti C, Maccario M, Grottoli S, Cavagnini F, Camanni F, Ghigo E.
    Int J Obes Relat Metab Disord; 1995 Feb 01; 19(2):108-12. PubMed ID: 7735336
    [Abstract] [Full Text] [Related]

  • 19. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism.
    Borges MH, DiNinno FB, Lengyel AM.
    Clin Endocrinol (Oxf); 1997 Jun 01; 46(6):713-8. PubMed ID: 9274702
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
    Maccario M, Tassone F, Gianotti L, Lanfranco F, Grottoli S, Arvat E, Muller EE, Ghigo E.
    J Clin Endocrinol Metab; 2001 Jan 01; 86(1):167-71. PubMed ID: 11231996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.